Utilizing Autologous Multipotent Mesenchymal Stromal Cells and -Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial

Figure 8

(a) The progress of DEXA bone mineral density (BMD) values in the trial and control group over time. The BMD value is expressed as the median percentage of the BMD values obtained from the first postoperative scan at 6 weeks. No significant difference was observed between both groups of patients. (b) The box plot graph showing BMD values in the control group. (c) The box plot graph showing BMD values in the trial group. The bottom and top of the box are the first and third quartiles, and the band inside the box is the median. The ends of the whiskers represent the minimum and maximum.

(a)

(b)

(c)